OUR CLINICAL TRIALS

  • Status

  • Scenario

  • Patients population

  • Phase

  • Solti Program

  • Sites

  • Search

  • Reset


AWARE-1
A window-of-opportunity Study of pelareorep in Early Breast Cancer Leer mas
AZD8931 – THYME
A Phase I/II Multi-centre Study of AZD8931 in Combination With Weekly Paclitaxel to Assess the Leer mas
AZURE
A prospective, randomized, open label, clinical trial to determine whether adjuvant treatment with zoledronic acid Leer mas
BALI-1
Randomized Phase II trial with cetuximab and cisplatin in the treatment of ER-negative, PgRnegative, HER2-negative Leer mas
BEATRICE
An international, multi-center, open-label, 2-arm phase III trial of adjuvant bevacizumab in triple-negative breast cancer Leer mas
BRAVO
A phase III, randomized, open label, multicenter, controlled trial of niraparib versus physician’s choice in Leer mas
CA180P52 DASATINIB/EXEMESTANE
Randomized double-blind phase II trial of exemestane (Aromasin®) plus dasatinib versus exemestane plus placebo in Leer mas
CAPRICE (SOLTI-0702)
A phase II, open-label, multicenter clinical trial of pegylated liposomal doxorubicin (Caelyx®) as primary treatment Leer mas
CDK-PREDICT
Analysis of “CDKs 4/6” efficacy in combination with hormone treatment in HR+ HER2 negative breast Leer mas